Thursday , April 24 2025
Home / The Angry Bear (page 199)

The Angry Bear

Employer Healthcare Benefits Annual Survey 2023 Summary of Findings

This is a portion (1 of 6 observations) of a much longer Employer Healthcare Benefits article which would have been impossible to feature in entirety at AB. If I did so, much of it would probably go unread. I was interested in how much concern employees have about company healthcare insurance costs. In particular, I was looking at what employees thought about their plans and its affordability as show in chart 6. Costs, Inflation and Affordability...

Read More »

Initial claims on the cusp of turning lower YoY

Initial claims on the cusp of turning lower YoY  – by New Deal democrat Initial jobless claims dropped below 200,000 last week for the first time since January, and not too far from the 50+ year low of 182,000 set in September one year ago. Specifically, they declined -13,000 to 198,000. The four-week average declined -1,000 to 205,750, the lowest since February. Contrarily, with the usual one-week lag, continuing claims rose 29,000 to 1.734...

Read More »

A Chance to Modernize Prison Healthcare

A Chance to Modernize Health Care behind Bars, Section 1115 Medicaid Inmate Exclusion Waivers | NEJM, Brendan Saloner, Ph.D. California and Washington are the first states to receive waivers from the Centers for Medicare and Medicaid Services (CMS) regarding the Medicaid Inmate Exclusion Policy. The policy generally prohibits Medicaid from paying for health care for people who are incarcerated. That being said, ~2 million Americans were...

Read More »

The last holdout in housing data has turned; ‘recession watch’ for next 12 months remains

The last holdout in housing data has turned; ‘recession watch’ for next 12 months remains  – by New Deal democrat Last month I wrote that: “the biggest news was what happened with units under construction. The total declined slightly, as did single family units. But most significantly, for the first time since February 2021, multi-family units under construction also declined. “Why is this so important? Because, as this long term...

Read More »

The Speaker of the House Battle

It amazes me how far some people, errrrr politicians will extend themselves for opportunity, power, influence in Congress. Maybe I should not be calling them people? Maybe that is not amazing? Most of start off with their bad manners and aggressions, then do not have to live with and by their own decisions, and expect people to forgive and forget. They are definitely not like us. I wish the charade would end. Rep. Tom Cole Nominates Jim Jordan as...

Read More »

Like retail sales, motor vehicles lead the way in industrial production

Like retail sales, motor vehicles lead the way in industrial production  – by New Deal democrat As with retail sales earlier this morning, motor vehicle production is playing an outsized role in expansion this year. Industrial production as a whole rose 0.3% in September. But August was revised down by -0.2%, so on net it increased only 0.1%. Similarly, manufacturing production rose 0.4%, but with a -0.3% revision to August, was also only up...

Read More »

Whew

On this day, 18 October 2023, a group representing, at best, 10 percent of House Republicans, 5 percent of the total House, and 5 percent of the total populace came too close to getting Jim Jordan selected Speaker of the House. We came this close to a coup. Albeit partial, a coup. If they had been successful, as their first order of business, they would set about expunging Trump’s impeachments. ...

Read More »

Is peace realistic?

It is easy to think that those of us who favor a two-state solution are utopian dreamers.  The mantle of realism seems to rest naturally on those who insist on standing tough against a Palestinian state.  But this simple dichotomy has never been accurate, and the realist case for a renewed effort to achieve a stable peace between Israel and the Palestinians is getting stronger every day.  Seeking peace may well lead to failure, but the alternative...

Read More »

One Tenth of a Mg makes a big difference in a drug price and it has no clinical consequence

Interesting story about a pharma company taking an old drug finding a new usage for it at a particular dosage, filing a patent for the treatment at the specified dosage, and potentially blocking treatment of the disorder at a milligram higher dosage. Drug stores will not fill a prescription at a higher dosage if it is for the treatment of the disorder. Locked up both ways. And the cost to the patient went from pennies to ~$20/pill. A Price Jump...

Read More »